Baxter International Inc. (NYSE:BAX) Faces Challenges Despite Strong Sales
Baxter(US:BAX) Financial Modeling Prep·2026-02-13 03:14Baxter International Inc. (NYSE:BAX) reported a quarterly sales increase of 8% year over year, exceeding consensus estimates.The company's adjusted earnings per share (EPS) of 44 cents fell short of expectations due to an unfavorable product mix.Baxter's 2026 guidance projects flat sales growth and an EPS range below consensus estimates, contributing to a negative market reaction.Baxter International Inc. (NYSE:BAX) is a key player in the medical products industry, specializing in devices and therapies that ...